Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (21039)	4/21/1999 6:14:00 PM
From: Brent	Read Replies (1) \| Respond to of 23519

VLAD, I won't sell tomorrow, I am in it for the long haul. My cost basis is down to 5, so I can afford to hold for a while. I think you are missing the big picture. If you think I am complaining about not having revenues today, you're wrong. I am complaining about the obvious poor management. If there was good management, sales would be higher as we would have have approval sooner, AZ would be launching sooner, and we would have a domestic partner. The low revenues are not the problem, they are a symptom of the problem. Vivus does have 4 good products in the pipeline, but with the current track record who knows if they'll ever get them through FDA, approved, and selling in any kind of volume before Pfizer, AZ, LLY or so other drug company beats them to the punch. I am just not happy with the aggresiveness of management. Brent